Conference organizers need to manage hundreds of moving puzzle pieces to ensure their event is a success, so it’s not surprising that security sometimes slips down the list of priorities. However, if something does go wrong at your conference, the consequences can be huge. To help you avoid any nasty surprises on the day we’ve put together a list of technology tips that will help protect your attendees throughout the conference.
News and blog posts from our universe
Security risks conference organizers can’t ignore
Top trends for libraries in 2019
Academic libraries are constantly developing to ensure they can best support the changing needs of their students. As 2019 approaches, we’ve scoured the research from this year’s Charleston Library Conference to put together the biggest topics librarians around the world are working on right now. Read on to find out why technology, data, and early-stage research will play an integral role in the new year.
What the tech industry can teach academia
Without taking risks and challenging the status quo, the majority of the world’s biggest scientific breakthroughs would not have been possible. That’s why it’s all the more surprising that academia itself is often reluctant to embrace new ways of working and sharing results. Scientists work on their research in secrecy for months or years and then wait an average of 100 days from the moment they submit their paper until it ends up published in a journal. Early-stage findings are hidden, failures are rarely shared, and the online presence of scientific content is disjointed, meaning that valuable findings end up obscured from both researchers and the general public.
Researchers use machine learning and blood tests to detect cancer before symptoms appear
Researchers at the Princess Margaret Cancer Centre in Toronto today announced a new approach that shows promise for detecting cancer at a very early stage using blood tests. The method can detect cancer cells before any symptoms appear, at a stage where it is far easier to treat.
New immunotherapy study an important step in the hunt for a cure to HIV
With the help of antiretroviral therapy treatments, an HIV diagnosis is no longer a death sentence. In fact, patients who are tested for the disease and begin treatment at an early stage now have a similar life expectancy to those without the infection. However, while HIV is now referred to as a chronic, manageable illness, it still has no cure. Researchers are working hard to change this and a safety study published today in Molecular Therapy represents an important step forward in the hunt for an effective treatment. Scientists from the University of North Carolina successfully demonstrated the safety of a cell therapy involving the ex vivo expansion of T cells and their infusion in HIV positive patients in combination with antiretroviral (ART) drugs. We talked to co-senior study author David Margolis to find out more.